与Nirmatrelvir/Ritonavir治疗COVID-19的心血管药物相互作用:日常实践的考虑因素
Andrea Di Lenarda1, Nicola Ferri2,3, Massimiliano Lanzafame4
1Cardiovascular Center, Territory Specialist Department, Azienda Sanitaria Universitaria Giuliano Isontina - ASUGI Trieste, Italy.
European cardiology
|September 2, 2024
概括
患有心血管疾病的患者面临更高的COVID-19风险,可能需要早期用nirmatrelvir/ritonavir (Paxlovid®) 进行抗病毒治疗. 仔细管理药物相互作用对于这些患者的安全有效的COVID-19治疗至关重要.
科学领域:
- 药理学 药理学是指药理学的学科.
- 传染性疾病 传染性疾病
- 心脏病学 心脏病学
背景情况:
- 心血管疾病 (CVD) 是严重的COVID-19的一个重要风险因素.
- 建议在患有心血管疾病的患者进行早期抗病毒治疗.
- 尼尔马特里尔维尔/里托纳维尔 (Paxlovid®) 是一种已批准的COVID-19抗病毒治疗方法.
研究的目的:
- 审查nirmatrelvir/ritonavir的临床药理学. 这是一项研究.
- 确定和讨论与心血管疾病患者相关的潜在药物相互作用 (DDI).
- 为在这个患者群体中管理DDI提供指导.
主要方法:
- 对尼尔马特里尔维尔/里托纳维尔的临床药理学的综述.
- 在心血管患者中分析潜在的DDI与常见处方药物的分析.
- 专注于通过细胞染色体P450 3A4和P-糖蛋白代谢的药物,治疗指数狭窄.
主要成果:
- 涅玛特里尔维尔/里托纳维尔对DDI具有显著的潜力,特别是在心血管药物中.
- 通过CYP3A4或P-糖蛋白代谢的药物以及具有狭窄治疗指数的药物需要特别注意.
- 需要管理策略来平衡治疗效益与相互作用风险.
结论:
- 医生在给心血管疾病患者开处方尼马特里尔维尔/里托纳维尔时,必须意识到并积极管理DDI.
- 彻底的患者评估和对药物相互作用的了解对于安全治疗至关重要.
- 将COVID-19治疗的好处与DDI不良事件的风险相平衡至关重要.
相关概念视频
Antianginal Drugs: Nitrates and β-Blockers
547
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
547
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
404
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
404
Antihypertensive Drugs: Direct Renin Inhibitors
511
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
511
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
464
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
464
Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions
108
Renal clearance plays a pivotal role in drug elimination from the body and can be influenced by drug distribution and interactions. Understanding these factors is crucial in pharmacology as they impact the effectiveness and duration of drug therapy.
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
108
Cardiovascular Drugs: Classification based on Therapeutic Indications
2.1K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.1K


